@silsol is definately onto it. Don’t forget we already had a recent bio similar trial for Xolair (Omalizumab) conducted with Linear with a Chinese Biotech. Linear & PIQ are well know to each other, & it would not surprise me in the slightest if that’s the path Linear take with the COVID-19 vaccine as a certified Lab with enhanced capabilities for clinical trials.
Things have been so hectic with work, no time to look, Sorry @Eqz! Just one thing, don’t be complacent, there is a major concern with a second wave of community infection, especially now with lifting of restrictions.
There have been a lot of people working so hard on upcoming Covid-19 trials, but the best thing we’d see in this country is cases drying up & we may not need to go ahead, so please take care, some people have become far too complacent too soon. We have plenty more to get on with with clinical trials, or for some to complete.
The vaccine trial is important though, it won’t depend on infected people also. Fantastic post @silsol
PIQ Price at posting:
33.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)